Outsourcing

Articles

Successful outsourcing relationships in early phase drug-development analytics are driven by partnership.

Outsourcing Analytical Services in Early Drug Development

Agnes Shanley is senior editor of Pharmaceutical Technology.

CRLs put the brakes on drug development and damage corporate reputation and stock prices. Upfront investment and better sponsor oversight are ways to prevent them.

Avoiding Complete Response Letters

Research suggests that working with a single contract partner can reduce development time and improve economics.

Outsourcing: Does Focus Pay Off?

Joe DiMasi, director of economic analysis and research associate professor, Tufts Center for the Study of Drug Development (CSDD), discussed research into the impacts of working with single source contractors with Pharmaceutical Technology.

Reducing Development Timelines and Costs

The companies will be integrated to form the newly-branded AGC Biologics, which will specialize in customized contract development and manufacturing organization services for the scale-up and cGMP manufacture of protein-based therapeutics.

AGC Biologics, Biomeva, CMC Biologics Combine

Peter Soelkner is Managing Director of Vetter Pharma International GmbH, Germany.

Flexibility, innovation, and creativity are critical for success in navigating the challenges facing the bio/pharmaceutical industry.

A Changing Industry Brings New Challenges, but also Opportunities

KBI Biopharma's acquisition of Elion Labs expands KBI's biophysical and analytical characterization capabilities.

KBI Biopharma Acquires Elion Labs

The acquisition strengthens Charles River Laboratories’ capabilities in the oncology and immunology therapeutic areas.

Charles River Laboratories Acquires KWS BioTest

Adeline Siew is editor for Pharmaceutical Technology Europe. She is also science editor for Pharmaceutical Technology.

Pharma trends translate into increased need for not only external partners, but those will capabilities that can help advance today’s drug development and manufacturing challenges.

Small and Specialty Companies Shape Pharma’s Evolving Outsourcing Landscape

The companies will collaborate to produce and improve the recombinant properties of Aethlon’s Hemopurifier blood purification device.

Contract Development Services